Medicamen Biotech Market Cap

Medicamen Biotech has a market cap or net worth of 5.28 billion as of June 27, 2025. Its market cap has decreased by -12.71% in one year.

Market Cap

5.28B

Enterprise Value

5.58B

Revenue

1.63B

Ranking

n/a

PE Ratio

74.33

Stock Price

415.00

Market Cap Chart

Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 5.28B, an increase of 4,770.14%. That is a compound annual growth rate of 20.91%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	5.28B	-18.66%
Dec 31, 2024	6.50B	-14.77%
Dec 29, 2023	7.62B	-27.09%
Dec 30, 2022	10.45B	-3.50%
Dec 31, 2021	10.83B	86.37%
Dec 31, 2020	5.81B	39.31%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sun Pharmaceutical Industries	4,006.41B
Divi's Laboratories	1,748.51B
Cipla	1,222.71B
Apollo Hospitals Enterprise	1,012.53B
Zydus Lifesciences	988.07B
Mankind Pharma	950.72B
Aurobindo Pharma	652.36B
Fortis Healthcare	596.95B

Market Cap Rankings